BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Devgen NV Completes Succesful Private Placement

  October 1, 2009

   · 

  3 min read
• BioMidwest

  APP Pharmaceuticals Supports New USP Standards for Unfractionated Heparin

  October 1, 2009

   · 

  1 min read
• Deals

  Celldex Therapeutics, Inc. Announces Completed Acquisition of CuraGen Corporation

  October 1, 2009

   · 

  1 min read
• Bundling 2 Low-cost Heart Drugs Prevents Heart Attack and Stroke in Large, Diverse Population

  October 1, 2009

   · 

  1 min read
• Pharm Country

  Talecris Biotherapeutics CEO and Chairman Larry Stern to Ring the NASDAQ Stock Market Opening Bell

  October 1, 2009

   · 

  1 min read
• Deals

  Fovea Pharmaceuticals to be Acquired by Sanofi-Aventis (France) for up to $541 Million

  October 1, 2009

   · 

  2 min read
• Pharm Country

  Stanford University Presents New Data On Immuno-Potential of Hemispherx Biopharma’s Ampligen(R)

  October 1, 2009

   · 

  1 min read
• Business

  Sanofi-Aventis (France) and Merrimack Pharmaceuticals Inc. Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121; Merrimack Eligible to Receive up to $530 Million

  October 1, 2009

   · 

  5 min read
• Job Trends

  Eli Lilly and Company (JOBS) Announces Lilly China to Double Workforce

  October 1, 2009

   · 

  1 min read
• Deals

  Facet Biotech Board Rejects Biogen, Inc. Bid

  October 1, 2009

   · 

  10 min read